Suki Raises $90 Million Series E to Scale Healthcare AI Agents

Suki has closed a $90 million Series E financing round to scale its healthcare AI agents, the company announced in a report carried by Pulse 2.0.

The round makes Suki one of the better-funded players in the clinical AI assistant space, and the $90 million figure signals continued investor appetite for healthcare automation despite a tighter venture market.

What does the money fund?

Suki plans to put the Series E capital toward scaling its AI agents — software built to take administrative work off clinicians' plates. The company positions these agents as a way to reduce documentation burden and free up physician time.

The financing follows a broader industry push: healthcare systems are under pressure to cut administrative costs, and AI vendors are racing to prove their tools can deliver measurable savings without adding clinical risk.

Why healthcare AI agents, why now?

Investors keep betting on this category because the pain point is concrete. Doctors spend hours on documentation and administrative tasks, and health systems face labor shortages and margin pressure. AI agents that can automate parts of that workflow present a direct cost case.

Suki's $90 million raise gives it runway to expand its product line and distribution while the market consolidates around a handful of well-capitalized vendors.

What's the takeaway?

A nine-figure Series E for a healthcare AI company in this market is a statement: the segment is still attracting large checks, and Suki now has the capital to compete at scale.